1515.HK WACC - Weighted Average Cost of Capital

The WACC of China Resources Medical Holdings Company Ltd (1515.HK) is 9.6%.

The Cost of Equity of China Resources Medical Holdings Company Ltd (1515.HK) is 12.80%.

The Cost of Debt of China Resources Medical Holdings Company Ltd (1515.HK) is 4.55%.

	Range	Selected
Cost of equity	10.80% - 14.80%	12.80%
Tax rate	23.00% - 27.40%	25.20%
Cost of debt	4.00% - 5.10%	4.55%
WACC	8.2% - 11.1%	9.6%

WACC

1515.HK WACC calculation

Category	Low	High

Long-term bond rate	2.9%	3.4%
Equity market risk premium	6.0%	7.0%
Adjusted beta	1.32	1.57

Additional risk adjustments	0.0%	0.5%
Cost of equity	10.80%	14.80%

Tax rate	23.00%	27.40%
Debt/Equity ratio	0.51	0.51
Cost of debt	4.00%	5.10%

After-tax WACC	8.2%	11.1%


Selected WACC	9.6%

1515.HK's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for 1515.HK:

cost_of_equity (12.80%) = risk_free_rate (3.15%) + equity_risk_premium (6.50%) * adjusted_beta (1.32) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.